To include your compound in the COVID-19 Resource Center, submit it here.

Mott retires from NEA

Dave Mott, the former Smith Barney investment banker, CEO of MedImmune and longtime VC, has announced his retirement from New Enterprise

Read the full 216 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE